Ibigezweho, ibikenewe, imbogamizi, n'amahirwe yo gusesengura imiti ya chimique ivura isoko ningero zinganda, isesengura ryigabana ryisoko, imiterere ihiganwa, hamwe nibiteganijwe kugeza 2021-2027

Isoko rya chimie yisesengura rya clinique rikoresha uburyo bwiza cyane muri buri sesengura ryibanze nayisumbuye kugirango bapime imiterere yapiganwa, hamwe nabitabiriye isoko ry’indashyikirwa biteganijwe ko baziganje ku isoko ry’isesengura ry’imiti muri 2020-2025.
Biteganijwe ko ubwiyongere bugaragara bwibishushanyo mbonera bya chimie yubuvuzi bizasobanura inzira yiterambere ryisoko ryisesengura rya chimie clinique, kandi biteganijwe ko rizagera ku gaciro gakomeye mugihe kizaza.
Isesengura rya chimie clinique ni imashini yateguwe na mudasobwa ikoreshwa mu gusesengura no kumenya ibiri muri poroteyine n'isukari mu maraso.Izi mashini zitanga ibisubizo nyabyo mugihe gito gishoboka kuko zateye imbere cyane ikoranabuhanga kandi ryatejwe imbere kubwiyi ntego.Kora ibizamini bya chimie kugirango umenye imiterere yubuvuzi, nkimirire, imikorere yimpyiko, numwijima.Byongeye kandi, ibi bizamini bikunze gukoreshwa mukwiga imiterere yubuvuzi, harimo arteriosclerose, diyabete, na hyperlipidemiya.
Isoko ryisesengura rya chimique kwisi yose irashobora kugabanywa nibicuruzwa, ikizamini, akarere, nu mukoresha wa nyuma.Igice cyo kwipimisha ku isoko kigabanyijemo itsinda rya electrolyte, itsinda ryimpyiko, imiti idasanzwe, lipide, itsinda ryimikorere ya tiroyide, itsinda rya metabolism basal hamwe nitsinda ryumwijima.Igice cyibicuruzwa byisoko bigabanijwemo abasesengura, reagent nibindi bicuruzwa.Igice cya reagent cyisoko ryisesengura rya chimique kigabanyijemo ibipimo, kalibuteri, ibintu bifatika hamwe nizindi reagent.Isesengura igice cyisoko kigabanijwemo binini (ibizamini 1200-2000 / isaha), binini cyane (ibizamini 2000 / isaha), bito (ibizamini 400-800 / isaha) hamwe nubunini buciriritse (ibizamini 800-1200 / isaha) igice cyanyuma cyabakoresha cyisoko kigabanijwe mubitaro, ibigo byubushakashatsi bwamasomo, laboratoire yo gusuzuma nabandi bakoresha amaherezo.Urebye mu karere, isoko ry’isesengura ry’imiti ku isi igabanyijemo Amerika y'Amajyaruguru, Uburayi, Amerika y'Epfo, Aziya ya pasifika, n'Uburasirazuba bwo hagati na Afurika.
Kongera ibyifuzo mu nganda zita ku buzima n’iterambere ryinshi mu ikoranabuhanga ritera kuzamuka kw isoko
Bitewe n’ibikenerwa n’inganda zita ku buzima n’iterambere ryinshi mu ikoranabuhanga, ikoreshwa ry’abasesengura imiti y’ubuvuzi riziyongera vuba mu myaka icumi iri imbere.Intego nyamukuru ya chimie clinique nugusesengura amazi yimbere mumubiri no gutanga ubushishozi busobanutse.Ibizamini bya laboratoire gakondo byashizeho urufatiro rukomeye rwa chimie yubuvuzi bugezweho.Kurundi ruhande, tekinoroji yo kugerageza yateye imbere hamwe niterambere ryikoranabuhanga.Kugeza ubu, ibikoresho byongerewe imbaraga (nkabasesengura imiti) birashobora gukoreshwa muri laboratoire zikoresha ibizamini bitandukanye.
Iterambere ryibanze mugushushanya abasesenguzi ba chimie yubuvuzi bugezweho biteganijwe gusobanura iterambere ryisoko ryisesengura rya chimie clinique.Kunoza tekinoroji yumusaruro, gutera imbere mu ikoranabuhanga no kwinjiza porogaramu zigezweho ni bimwe mu bintu biteganijwe ko byihutisha iterambere ry’isoko ry’isesengura ry’imiti mu gihe kiri imbere.Ibigo byita ku barwayi, ibitaro, na laboratoire z’ubushakashatsi nizo zikoreshwa cyane mu isoko ry’isesengura ry’imiti ya chimie.
Bitewe nubushobozi buke bwabakoresha, Amerika ya ruguru biteganijwe ko izayobora isoko ryisesengura rya chimie clinique mugihe cyateganijwe
Bitewe nuko umukoresha afite ubushobozi buke, ibikorwa remezo bikomeye byubuvuzi hamwe n’ikoranabuhanga ryateye imbere, biteganijwe ko Amerika ya Ruguru izayobora isoko ry’isesengura ry’imiti mu gihe cyagenwe.Bitewe n’ubushake bugenda bwiyongera bw’imodoka, ubukangurambaga bw’abarwayi bo mu karere kugira ngo babungabunge ubuzima bwo kwirinda, ndetse n’ubukungu bukomeje kunozwa, biteganijwe ko akarere ka Aziya-Pasifika nako kazatera imbere ku isoko ku kigero kinini mu gihe cya igihe cyo guteganya.
Amerika y'Amajyaruguru (Amerika, Kanada, Mexico), Uburayi (Ubwongereza, Ubufaransa, Ubudage, Uburusiya, Uburayi busigaye), Aziya ya pasifika (Ubushinwa, Koreya, Ubuhinde, Ubuyapani, Aziya ya pasifika), LAMEA, Amerika y'Epfo, Uburasirazuba bwo hagati, Afurika
Raporo yubushakashatsi bwuzuye @ https://brandessenceresearch.com/imiti- na-ibikoresho
Ubushakashatsi bwisoko rya Brandessence butangaza raporo yubushakashatsi bwisoko nubushishozi bwubucuruzi bwakozwe nabasesenguzi babishoboye kandi bafite uburambe.Raporo yacu yubushakashatsi irashobora gukoreshwa mubikorwa bitandukanye byinganda zihagaritse, harimo indege, ibiribwa n'ibinyobwa, ubuvuzi, amakuru n’ikoranabuhanga mu itumanaho, ubwubatsi, n’inganda zikora imiti.Raporo yubushakashatsi bwisoko ryibanze cyane kubayobozi bakuru, abashinzwe iterambere ryubucuruzi, abashinzwe kwamamaza, abajyanama, abayobozi bakuru, abayobozi bashinzwe amakuru, abayobozi bakuru bashinzwe ibikorwa, abayobozi, ibigo, amashyirahamwe na PhD.abanyeshuri.Dufite ikigo cyo kugemura i Pune, mu Buhinde, kandi ibiro byacu byo kugurisha biri i Londres.
Inkingo za mRNA hamwe n’ubuvuzi ingano y’isoko: Ku bijyanye n’amafaranga yinjira, icyifuzo cy’isi yose ku nkingo za mRNA n’ubuvuzi bw’isoko muri 2019 cyari miliyoni 587.7 z'amadolari y’Amerika, bikaba biteganijwe ko kizagera kuri miliyoni 2.91119 z'amadolari ya Amerika mu 2026, kikiyongera ku kigero cyo kwiyongera ku mwaka. ya 28.51% kuva 2020 kugeza 2020. Muri 2026.
Ingano yisoko rya software ihuza isoko: Isoko ryitumanaho rya software ryisi yose ryazamutse ku kigero kinini cy’iterambere rya buri mwaka kingana na 14.67%.Amafaranga yinjiye muri 2018 yari miliyari 17.54 z'amadolari y'Amerika kandi biteganijwe ko mu 2025 azagera kuri miliyari 38.83 z'amadolari y'Amerika.
Isoko ryita ku buzima bw’umuryango: Ingano y’isoko ryita ku buzima bw’umuryango muri 2019 yari miliyari 168.4 z’amadolari y’Amerika, bikaba biteganijwe ko izagera kuri miliyari 293.6 z’amadolari ya Amerika mu 2026, aho izamuka ry’umwaka ryiyongera rya 8.2% mu gihe giteganijwe.


Igihe cyo kohereza: Jul-05-2021